Trimebutine.
Trospium.
Tuberculin, when intended for human use. (S4)
Tulobuterol, except when contained in respirator solutions. (S3)
Vaccines, when intended for human use.
Schedule 3
[Schedule 3 added by s. 36 of Act No. 65 of 1974, substituted by Government Notices No. R.420 of 7
March, 1975, No. R.2244 of 28 November, 1975, No. R.575 of 2 April, 1976 and No. R.2082 of 5
November, 1976, amended by Government Notices No. R.278 of 25 February, 1977, No. R.437 of 1
April, 1977, No. R.1674 of 18 August, 1978 (as amended by Government Notice No. R.2410 of 8
December, 1978), No. R.1926 of 31 August, 1979, No. R.2507 of 9 November, 1979, No. R.658 of 27
March, 1981, No. R.1289 of 14 June, 1985 and No. 154 of 31 January, 1986, substituted by
Government Notice No. 225 of 17 February, 1989, amended by Government Notices No. R.2841 of 7
December, 1990, No. R.2169 of 6 September, 1991, and No. R.775 of 7 May, 1993, repealed, and
subsequently re-inserted (after amendment), by s. 21 of Act No. 94 of 1991, amended by Government
Notice No. R.1556 of 16 September, 1994, by Government Notice No. R.673 of 12 May, 1995, by
Government Notice No. R.42 of 19 January, 1996, by Government Notice No. R.1496 of 13 September,
1996, by Government Notice No. R.1203 of 15 October, 1999 and by Government Notice No. R.1077 of
3 November, 2000, repealed by s. 27 of Act No. 90 of 1997 and inserted by Government Notice No.
R.509 in Government Gazette 24727 of 10 April, 2003 with effect from 2 May, 2003.]
Wording of Sections
(a)
All substances referred to in this Schedule are excluded when specifically packed,
labelled and used for—
(i)
industrial purposes including the manufacture or compounding of consumer items or
products, which have no pharmacological action or medicinal purpose; and
(ii)
analytical laboratory purposes.
(b)
All substances referred to in this Schedule include the following:
(i)
The salts and esters of such substances, where the existence of such salts and esters
is possible; and
(ii)
all preparations and mixtures of such substances where such preparations and
mixtures are not expressly excluded.
(c)
In terms of Section 22A (5) ( f ) of the Act, a practitioner, nurse or a person registered
under the Health Professions Act, 1974, other than a medical practitioner or dentist, may prescribe and
supply to patients under their care, the Schedule 3 substances and medicines provided for in the
Annexures, only within their scope of practice and subject to the conditions determined by the Medicines
Control Council. The conditions and the Annexures will be published in the Gazette.
Acamprosate.
Acebutolol.
Aceclofenac.
Acetazolamide.
Acetohexamide.
Acetylcholine, when intended for ophthalmic use.
Acipimox.
Adapalene.
Adrenaline (epinephrine); ophthalmic preparations thereof, when intended for glaucoma. (S2, S4)
Alclofenac.
Alendronic acid.
Allopurinol.
Alprenolol.
Amiloride.
Amodipine.
Ancrod.
Anthiolimine, when intended for injection.
Arsanilic acid.
Atenolol.
Atropine; ophthalmic preparations thereof. (S2)
Azapropazone.
Balsalazide.
Bamidipine.
Beclamide.
Benazepril.
Bendazac.
Benfluorex.
Benoxaprofen.
Benzbromarone.